• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
First-in-man implantation of the retrievable and repositionable VenusA-Plus valve.可回收和可重新定位的VenusA-Plus瓣膜首次人体植入。
World J Emerg Med. 2018;9(1):64-66. doi: 10.5847/wjem.j.1920-8642.2018.01.010.
2
Transcatheter aortic valve replacement with the VenusA-Pro and VenusA-Plus systems: preliminary experience in China.使用VenusA-Pro和VenusA-Plus系统进行经导管主动脉瓣置换术：中国的初步经验。
Front Cardiovasc Med. 2023 Aug 24;10:1169590. doi: 10.3389/fcvm.2023.1169590. eCollection 2023.
3
1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.120例严重主动脉瓣狭窄高危手术患者使用可完全重新定位和回收的Lotus经导管主动脉瓣置换瓣膜的1年结局：REPRISE II研究结果
JACC Cardiovasc Interv. 2016 Feb 22;9(4):376-384. doi: 10.1016/j.jcin.2015.10.024.
4
Transcatheter aortic valve replacement in the treatment of bicuspid aortic stenosis with "down-size" interventional valves: procedural and mid-term follow-up.使用“减径”介入瓣膜经导管主动脉瓣置换术治疗二叶式主动脉瓣狭窄：手术过程及中期随访
J Thorac Dis. 2024 Jan 30;16(1):593-603. doi: 10.21037/jtd-23-1885. Epub 2024 Jan 22.
5
Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.经导管主动脉瓣置换术治疗严重症状性主动脉瓣狭窄的可重定位瓣膜系统：REPRISE II 研究的 30 天主要终点结果。
J Am Coll Cardiol. 2014 Sep 30;64(13):1339-48. doi: 10.1016/j.jacc.2014.05.067.
6
Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.在常规临床实践中使用可重定位和完全可回收的主动脉瓣：RESPOND 研究和 RESPOND 扩展队列。
JACC Cardiovasc Interv. 2019 Jan 14;12(1):38-49. doi: 10.1016/j.jcin.2018.10.052.
7
TRINITY heart valve prosthesis: a novel repositionable and retrievable transapical transcatheter aortic valve system.TRINITY心脏瓣膜假体：一种新型的可重新定位和可回收的经心尖经导管主动脉瓣系统。
EuroIntervention. 2015 Mar;10(11):1332-5. doi: 10.4244/EIJY14M07_08.
8
First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†.首次使用新一代可重新定位和可回收经导管心脏瓣膜，在未进行球囊预扩张的情况下经股动脉进行经导管主动脉瓣植入术† 。
Interact Cardiovasc Thorac Surg. 2017 May 1;24(5):659-662. doi: 10.1093/icvts/ivw446.
9
Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.经导管植入莲花瓣膜进行主动脉瓣置换术后的操作及30天临床结果：相关研究结果
Catheter Cardiovasc Interv. 2017 Dec 1;90(7):1206-1211. doi: 10.1002/ccd.26914. Epub 2017 Feb 1.
10
Valve embolization with a second-generation fully-retrievable and repositionable transcatheter aortic valve.使用第二代完全可回收和可重新定位的经导管主动脉瓣进行瓣膜栓塞术。
Int J Cardiol. 2016 Nov 15;223:867-869. doi: 10.1016/j.ijcard.2016.08.327. Epub 2016 Aug 23.

引用本文的文献

1
Transcatheter aortic valve replacement with the VenusA-Pro and VenusA-Plus systems: preliminary experience in China.使用VenusA-Pro和VenusA-Plus系统进行经导管主动脉瓣置换术：中国的初步经验。
Front Cardiovasc Med. 2023 Aug 24;10:1169590. doi: 10.3389/fcvm.2023.1169590. eCollection 2023.
2
Anatomic predictor of severe prosthesis malposition following transcatheter aortic valve replacement with self- expandable Venus-A Valve among pure aortic regurgitation: A multicenter retrospective study.单纯主动脉瓣反流患者经导管主动脉瓣置换术使用自膨式Venus-A瓣膜后严重假体位置不当的解剖学预测因素：一项多中心回顾性研究。
Front Cardiovasc Med. 2022 Dec 8;9:1002071. doi: 10.3389/fcvm.2022.1002071. eCollection 2022.
3
Effect of Eccentric Calcification of an Aortic Valve on the Implant Depth of a Venus-A Prosthesis During Transcatheter Aortic Valve Replacement: A Retrospective Study.经导管主动脉瓣置换术中主动脉瓣偏心钙化对Venus-A人工瓣膜植入深度的影响：一项回顾性研究
Front Physiol. 2021 Aug 6;12:718065. doi: 10.3389/fphys.2021.718065. eCollection 2021.
4
Anatomical Predictors of Valve Malposition During Self-Expandable Transcatheter Aortic Valve Replacement.自膨胀式经导管主动脉瓣置换术中瓣膜位置异常的解剖学预测因素
Front Cardiovasc Med. 2021 Jul 12;8:600356. doi: 10.3389/fcvm.2021.600356. eCollection 2021.
5
The first two cases of transcatheter mitral valve repair with ARTO system in Asia.亚洲首例使用ARTO系统进行经导管二尖瓣修复的两例病例。
World J Emerg Med. 2020;11(1):33-36. doi: 10.5847/wjem.j.1920-8642.2020.01.005.
6
Ascending aortic dilatation rate after transcatheter aortic valve replacement in patients with bicuspid and tricuspid aortic stenosis: A multidetector computed tomography follow-up study.二叶式和三叶式主动脉瓣狭窄患者经导管主动脉瓣置换术后升主动脉扩张率：一项多层螺旋计算机断层扫描随访研究。
World J Emerg Med. 2019;10(4):197-204. doi: 10.5847/wjem.j.1920-8642.2019.04.001.
7
The first four cases of successful NeoChord procedure in mainland China.中国大陆首例成功实施NeoChord手术的4个病例。
World J Emerg Med. 2019;10(3):133-137. doi: 10.5847/wjem.j.1920-8642.2019.03.001.

本文引用的文献

1
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
2
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis.经导管主动脉瓣置换术治疗二叶式主动脉瓣与三叶式主动脉瓣狭窄的结局比较。
J Am Coll Cardiol. 2017 May 30;69(21):2579-2589. doi: 10.1016/j.jacc.2017.03.017. Epub 2017 Mar 18.
3
Evaluation of the safety and efficacy of transcatheter aortic valve implantation in patients with a severe stenotic bicuspid aortic valve in a Chinese population.中国人群中严重狭窄二叶式主动脉瓣患者经导管主动脉瓣植入术的安全性和有效性评估。
J Zhejiang Univ Sci B. 2015 Mar;16(3):208-14. doi: 10.1631/jzus.B1500017.
4
Morphological characteristics of severe aortic stenosis in China: imaging corelab observations from the first Chinese transcatheter aortic valve trial.中国重度主动脉瓣狭窄的形态学特征：来自中国首例经导管主动脉瓣试验的影像核心实验室观察结果
Catheter Cardiovasc Interv. 2015 Mar;85 Suppl 1:752-61. doi: 10.1002/ccd.25863. Epub 2015 Feb 19.

可回收和可重新定位的VenusA-Plus瓣膜首次人体植入。

First-in-man implantation of the retrievable and repositionable VenusA-Plus valve.

作者信息

Liu Xian-Bao, He Yu-Xin, Liu Chun-Hui, Wang Li-Han, Gao Feng, Yu Lei, Dong Ai-Qiang, Kong Min-Jian, Chen Ji-Fang, Xu Yong, Zhou Qi-Jing, Yan Min, Wang Jian-An

机构信息

Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Cardiovascular Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

World J Emerg Med. 2018;9(1):64-66. doi: 10.5847/wjem.j.1920-8642.2018.01.010.

DOI:10.5847/wjem.j.1920-8642.2018.01.010
PMID:29290898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5717379/
Abstract

BACKGROUND

No retrievable and repositionable second generation transcatheter aortic valve is available in China. Here, we report the first-in-man implantation of the retrievable and repositionable VenusA-Plus valve.

METHODS

A 76-year-old patient with symptomatic severe aortic stenosis and high surgical risk (STS 13.8%) was recommended for transcatheter aortic valve replacement (TAVR) by heart valve team. Type 0 bicuspid aortic valve with asymmetric calcification was identified by dual source computed tomography, and the unfavorable anatomies increased the possibility of malposition and paravalvular leakage during TAVR. Therefore, we used the retrievable and repositionable VenusA-Plus valve for the patient.

RESULTS

Transfemoral TAVR was performed under local anesthesia with sedation, and a 26mm VenusA-Plus valve was successfully implanted. No transvalvular pressure gradient and trace paravalvular leakage were found.

CONCLUSION

The successful first-in-man implantation indicates the retrievable and repositionable VenusA-Plus valve is feasible in complicated TAVR cases such as bicuspid aortic valve.

摘要

背景

中国尚无可回收和重新定位的第二代经导管主动脉瓣。在此，我们报告首例可回收和重新定位的VenusA-Plus瓣膜人体植入情况。

方法

一名76岁有症状的严重主动脉瓣狭窄且手术风险高（胸外科医师协会评分13.8%）的患者被心脏瓣膜团队推荐行经导管主动脉瓣置换术（TAVR）。通过双源计算机断层扫描确定为0型二叶式主动脉瓣伴不对称钙化，这种不利的解剖结构增加了TAVR期间瓣膜位置不当和瓣周漏的可能性。因此，我们为该患者使用了可回收和重新定位的VenusA-Plus瓣膜。

结果

在局部麻醉加镇静下进行经股动脉TAVR，成功植入一枚26mm的VenusA-Plus瓣膜。未发现跨瓣压差，瓣周漏微量。

结论

首例人体成功植入表明，可回收和重新定位的VenusA-Plus瓣膜在诸如二叶式主动脉瓣等复杂TAVR病例中是可行的。